17-35977594-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004590.4(CCL16):c.335G>T(p.Gly112Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,612,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004590.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCL16 | NM_004590.4 | c.335G>T | p.Gly112Val | missense_variant | 3/3 | ENST00000611905.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCL16 | ENST00000611905.2 | c.335G>T | p.Gly112Val | missense_variant | 3/3 | 1 | NM_004590.4 | P1 | |
CCL16 | ENST00000613642.4 | c.260G>T | p.Gly87Val | missense_variant, NMD_transcript_variant | 2/3 | 3 | |||
CCL16 | ENST00000610493.1 | c.*405G>T | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251422Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135866
GnomAD4 exome AF: 0.000149 AC: 217AN: 1460376Hom.: 0 Cov.: 31 AF XY: 0.000150 AC XY: 109AN XY: 726488
GnomAD4 genome AF: 0.000125 AC: 19AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.335G>T (p.G112V) alteration is located in exon 3 (coding exon 3) of the CCL16 gene. This alteration results from a G to T substitution at nucleotide position 335, causing the glycine (G) at amino acid position 112 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at